Krystal Biotech Inc
KRYS
Market Cap$4.87B
Close$
$214.06
26.8% upside
Current Fair Value
26.8% upsideUndervalued by 26.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.87 Billion |
|---|---|
| Enterprise Value | $4.54 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $3.12 |
| Beta | 0.75 |
| Outstanding Shares | 28,755,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 54.37 |
|---|---|
| PEG | -81.95 |
| Price to Sales | 21.1 |
| Price to Book Ratio | 5.28 |
| Enterprise Value to Revenue | 18.79 |
| Enterprise Value to EBIT | 71.51 |
| Enterprise Value to Net Income | 86 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
ESG Score
No data